Investigating the Role of Wild-type and Mutant Copper-zinc Superoxide Dismutase Amyloid in Amyotrophic Lateral Sclerosis

Investigating the Role of Wild-type and Mutant Copper-zinc Superoxide Dismutase Amyloid in Amyotrophic Lateral Sclerosis
Author: Pik Kay Chan
Publisher:
Total Pages: 120
Release: 2013
Genre:
ISBN:

Abnormal intracellular protein inclusions are consistently observable in the motor neurons affected by amyotrophic lateral sclerosis (ALS), also commonly referred as Lou Gehrig's disease. This disease was named after the famous Hall of Fame baseball player, Lou Gehrig, who suddenly experienced loss of physical strength and was diagnosed with ALS. The most prevalent hypothesis regarding the mechanism of ALS points to a toxic gain of function resulting from protein misfolding and aggregation. In the SOD1-ALS transgenic mouse model, protein aggregates composed of primarily full length apo SOD1 are consistently found in the spinal cords of mice exhibiting ALS symptoms. Moreover, these aggregates possess a filamentous structure, suggesting the involvement of SOD1 amyloid fibril in ALS pathology. Research on understanding the formation mechanism of SOD1 fibrils spurred over the past few years. Scientists are now convinced that the demetallated form of SOD1 is the most susceptible to aggregation. In this dissertation, we sought to understand the molecular mechanism by which apo SOD1 rearranges to adopt the fibrillar structure, seek SOD1 amyloid inhibitors as potential therapeutic leads, and use small molecules to modulate and stabilize SOD1 oligomeric intermediates from the amyloid pathway that have never been characterized before. We found that the SOD1 amyloid core is composed of the N-terminal sequence 1-63. The N-terminal tryptic fragment 1-69 is consistently the most trypsin resistant in all the fibrils examined, including WT and six SOD1 mutants. WT fibril displays regular twist pattern along the lateral axis with an average helical pitch distance of 62 nm. While some mutants (L38V, G93A, and G93S) have similar twist pattern as WT, a single point mutation resides within the fibril core can alter the overall amyloid morphology. This is most evident in mutants such as G37R and G41D. We successfully discovered several SOD1 amyloid inhibitors. Studies from a selection of SOD1 amyloid inhibitors (non-SOD1 synthetic peptides and small molecules) suggest that although peptides exhibiting a beta-strand conformation, such as DpV16 and DpV19, effectively inhibit SOD1 amyloid formation, peptides lacking beta-strand secondary structure, such as AzV31 and colivelin-tat are also effective. Out of all the inhibitors tested, only small molecules such as EGCG (a green tea derived flavonoid) and CLR01 (a molecular tweezer) formed stable oligomers with SOD1. SOD1 oligomers were never observed with peptide inhibitors. DpV16 was able to inhibit the initiation of fibrillation by reduced apo SOD1 but had no effect on the elongation phase, suggesting that it might prevent the formation of amyloid-competent nuclei. For the first time, we characterized SOD1 oligomers isolated from the in-vitro fibrillation assay. These CLR01-stabilized oligomers have an estimated molecular mass of 87,000 and exhibit a significant amount of beta-sheet content.

Copper, Zinc Superoxide Dismutase Misfolding in Amyotrophic Lateral Sclerosis

Copper, Zinc Superoxide Dismutase Misfolding in Amyotrophic Lateral Sclerosis
Author: Rishi Rakhit
Publisher:
Total Pages: 494
Release: 2009
Genre:
ISBN: 9780494591352

Amyotrophic lateral sclerosis (ALS) is characterized by motor neuron degeneration resulting in progressive paralysis and death. The only known cause of typical ALS is mutations in SOD1; these predominantly missense mutations produce a toxic gain-of-function in the enzyme Cu/Zn superoxide dismutase (SOD1). The prevailing hypotheses regarding the mechanism of toxicity were (a) oxidative damage from aberrant SOD1 redox chemistry, and (b) misfolding of the mutant protein. The goal of this thesis was to investigate the molecular mechanisms of the mutant SOD1 (mSOD1) misfolding and toxicity.To interrogate the in vivo misfolding pathway of SOD1, we used its high-resolution structure to create an antibody that reacts with monomer/misfolded SOD1 but not the native dimer. Upon verifying the reactivity of this antibody, we showed that monomer/misfolded SOD1 is found in a human case of familial ALS and in transgenic animal models of ALS. Misfolded SOD1 is found primarily in affected cells, motor neurons. Misfolded SOD1 is also initially absent, but appears prior to symptom onset. These observations together suggest a causal role for SOD1 misfolding through a monomeric intermediate in ALS pathogenesis.Because oxidation of SOD1 primarily affected the metal-binding His residues, we hypothesized that oxidation of wild-type, holo-SOD1 should lead to aggregation. Increasing the concentration of wild-type SOD1 in oxidation reactions produced aggregates similar to those observed earlier. Both wild-type and mSOD1 aggregation kinetics revealed an initial decrease in particle size rather than a monotonic increase using dynamic light scattering. This was consistent with the conversion of SOD1, normally an obligate homodimer, into monomers prior to aggregation. This observation was confirmed using analyatical ultracentrifugation. The common aggregation pathway for wild-type and mSOD1 suggested a mechanism for sporadic ALS caused by SOD1 misfolding.We proposed that oxidative damage to SOD1 itself could cause its misfolding and aggregation. To investigate this hypothesis, we subjected purified SOD1 in vitro to metal catalyzed oxidation. Oxidation of SOD1 produced aggregates reminiscent of those observed in ALS pathology. Aggregation propensity of zinc-deficient SOD1 and several mSOD1s known to have lower zinc-binding affinity was proportional to partial unfolding. Oxidation of SOD1 caused conversion of several His residues to 2-oxo-histidine.

Folding and Stability Studies on Amyotrophic Lateral Sclerosis-associated Apo Cu, Zn Superoxide Dismutases

Folding and Stability Studies on Amyotrophic Lateral Sclerosis-associated Apo Cu, Zn Superoxide Dismutases
Author: Kenrick Allistair Vassall
Publisher:
Total Pages: 225
Release: 2009
Genre:
ISBN:

Amyotrophic lateral sclerosis (ALS) is a debilitating, incurable, neurodegenerative disease characterized by degradation of motor neurons leading to paralysis and ultimately death in ~3-5 years. Approximately 10% of ALS cases have a dominant inheritance pattern, termed familial ALS (fALS). Mutations in the gene encoding the dimeric superoxide scavenger Cu, Zn superoxide dismutase (SOD), were found to be associated with ~20% of fALS cases. Over 110 predominantly missense SOD mutations lead to fALS by an unknown mechanism; however, it is thought that mutant SOD acquires a toxic gain of function. Mice as well as human post mortem studies have identified mutant SOD-rich aggregates in affected neurons, leading to the hypothesis that mutations in SOD increase the tendency of the protein to form toxic aggregates. SOD has a complex maturation process whereby the protein is synthesized in an apo or demetalated state, followed by formation of an intramolecular disulfide bond and binding of Zn2+ and Cu2+. Each of these post-translational modifications increases the stability of the protein. SOD has been shown to aggregate more readily from destabilized immature states, including the apo state both with and without the disulfide bond, highlighting the importance of these states. Thermal unfolding monitored by differential scanning calorimetry (DSC) and chemical denaturation monitored by optical spectroscopy were used to elucidate the folding mechanism and stability of both the apo SOD disulfide-intact and disulfide-reduced states. Chemically and structurally diverse fALS-associated mutants were investigated to gain insights into why mutant SODs may be more prone to misfold and ultimately aggregate. The mutations were introduced into a pseudo wild-type (PWT) background lacking free cysteines, resulting in highly reversible unfolding amenable to accurate thermodynamic analysis. Similarly to what was previously described for fully metallated (holo) SODs, chemical denaturation of the apo disulfide-intact SODs is well described by a 3-state dimer mechanism with native dimer, monomeric intermediate and unfolded monomer populated at equilibrium. Although removal of metals has a relatively small effect on the stability of the dimer interface, the stability of the monomer intermediate is dramatically reduced. Thermal unfolding of some disulfide-intact apo SOD mutants as well as PWT is well described by a 2-state dimer mechanism, while others unfold via a 3-state mechanism similar to chemical denaturation. All but one of the studied disulfide-intact apo mutations are destabilizing as evidenced by reductions in [Delta]G of unfolding. Additionally, several mutants show an increased tendency to aggregate in thermal unfolding studies through increased ratios of van't Hoff to calorimetric enthalpy (HvH/ Hcal ). The effects of the mutations on dimer interface stability in the apo disulfide-intact form were further investigated by isothermal titration calorimetry (ITC) which provided a quantitative measure of the dissociation constant of the dimer (Kd). ITC results revealed that disulfide-intact apo SOD mutants generally have increased Kd values and hence favor dimer dissociation to the less stable monomer which has been proposed to be a precursor to toxic aggregate formation. Reduction of the disulfide bond in apo SOD leads to marked destabilization of the dimer interface, and both thermal unfolding and chemical denaturation of PWT and mutants are well described by a 2-state monomer unfolding mechanism. Most mutations destabilize the disulfide-reduced apo SOD to such an extent that the population of unfolded monomer under physiological conditions exceeds 50%. The disulfide-reduced apo mutants show increased tendency to aggregate relative to PWT in DSC experiments through increased HvH /Hcal, low or negative change in heat capacity of unfolding and/or decreased unfolding reversibility. Further evidence of enhanced aggregation tendency of disulfide-reduced apo mutants was derived from analytical ultracentrifugation sedimentation equilibrium experiments that revealed the presence of weakly associated aggregates. Overall, the results presented here provide novel insights into SOD maturation and the possible impact of stability on aggregation.

Measuring Protein Metal Binding Via Mass Spectrometry

Measuring Protein Metal Binding Via Mass Spectrometry
Author: Timothy W. Rhoads
Publisher:
Total Pages: 139
Release: 2012
Genre: Amyotrophic lateral sclerosis
ISBN:

Amyotrophic lateral sclerosis (ALS) is a devastating disease characterized by the progressive degeneration of motor neurons. Dominantly-inherited mutations to the antioxidant enzyme Cu, Zn superoxide dismutase (SOD1) cause 3-6% of all ALS cases. The complete mechanism behind the toxicity of mutant SOD1 remains unclear, although significant evidence points to aberrant or incomplete metal-binding having a role in a toxic gain-of-function. However, the relevance of the metal-binding of SOD1 to mutant-SOD1-linked ALS remains controversial. Direct assessments of protein metal-binding from transgenic, SOD1-overexpressing rodent models of the disease are difficult to acquire due to the non-covalent nature of the interaction. The relatively small amount of disease-afflicted spinal cord tissue in which the motor neurons reside compounds the difficulty of measuring the protein metal binding of SOD1 from transgenic mice. This dissertation addresses the metals bound to SOD1 throughout the disease course in transgenic mice using a novel mass spectrometry assay. The methodology developed here offers the first detailed examination of partially unfolded intermediates of SOD1 present in the spinal cord of pre-symptomatic, symptomatic, and end-stage transgenic mice overexpressing the ALS-associated SOD1 mutation G93A (glycine mutated to alanine at position 93). These results were compared to age-matched transgenic mice expressing wild-type SOD1 that do not develop ALS symptoms. To extract SOD1 from relevant spinal cord tissue, a 300 [micro]m necropsy punch was used to remove a small piece of tissue from the ventral or dorsal gray matter of a 1 mm-thick slice of spinal cord. Physiological salts that interfere with electrospray mass spectrometry were removed by binding the proteins to a C4 Ziptip®, a pipette tip containing hydrophobic, reversed-phase packing material. Washing the Ziptip-bound proteins with water eliminated interfering salts. Bound proteins could then be eluted into a mass spectrometer with low concentrations of acetonitrile plus formic acid. Electrospray ionization conditions were determined that could keep both copper and zinc bound to SOD1. Using a high-resolution Fourier transform-ion cyclotron resonance mass spectrometer, we used the assay to collect isotopically-resolved protein mass data. Theoretical protein isotope distributions were calculated from the empirical formulas of SOD1 and matched to the experimental data with a least squares fitting algorithm to determine the multiple intermediates of SOD1 present. Spinal cord tissue, wild-type in particular, was notable for containing significantly more one-metal SOD1 than any other tissue, despite having 3-fold less SOD1 than liver. We quantitatively compared the levels of soluble, partially unfolded intermediates of SOD1 from wild-type and G93A SOD1 spinal cords. Wild-type mouse spinal cord contained significantly more of all of the partially unfolded intermediates copper-deficient SOD1, disulfide reduced SOD1, and apo SOD1. The amount of zinc-containing SOD1 was exceptionally high in wild-type mice, comprising 60% of the total SOD1 in wild-type spinal cord. The larger amounts of these SOD1 intermediates in wild-type transgenic mice indicate that they are not directly responsible for toxicity in vivo. However, copper-containing, zinc-deficient SOD1 was the one species found in higher concentrations in G93A SOD1 spinal cord. The concentration was on average 0.6-0.8 [micro]M in G93A spinal cord, compared to 0.1-0.3 [micro]M zinc-deficient SOD1 found in the wild-type mouse spinal cord. A concentration above 0.5 [micro]M zinc-deficient SOD1 was sufficient to induce motor neuron death in vitro. These results suggest that copper-containing, zinc-deficient SOD1 could be the toxic species responsible for motor neuron death in ALS.